Last quarter (Q0 0), Estrella Immunopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Estrella Immunopharma's net income was $-3.38M. See Estrella Immunopharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 24	Dec 22	Dec 21
Total Revenue	$ 50.00K	$ 50.00K	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ 50.00K	$ 50.00K	$ ―	$ ―
Operating Expense	$ 7.80M	$ 7.31M	$ 1.37M	$ 178.99K
Operating Income	$ -7.82M	$ -7.31M	$ -1.57M	$ -249.15K
Net Non Operating Interest Income Expense	$ ―	$ ―	$ ―	$ 1.43K
Other Income Expense	$ ―	$ ―	$ -654.07K	$ -1.43K
Pretax Income	$ -7.80M	$ -7.31M	$ -915.46K	$ -247.72K
Tax Provision	$ 1.63K	$ 1.63K	$ 80.65K	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -7.80M	$ -7.31M	$ -1.25M	$ -107.41K
Basic EPS	$ -0.28	$ -0.27	$ -0.22	$ -1.52
Diluted EPS	$ -0.28	$ -0.27	$ -0.22	$ -1.52
Basic Average Shares	$ 108.37M	$ 27.10M	$ 4.34M	$ 1.18M
Diluted Average Shares	$ 108.37M	$ 27.10M	$ 4.34M	$ 1.18M
Dividend Per Share	$ 2.00	$ 1.00	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 7.80M	$ 7.31M	$ 1.37M	$ 178.99K
Net Income From Continuing And Discontinued Operation	$ -7.80M	$ -7.31M	$ -996.10K	$ -247.72K
Normalized Income	$ -4.37M	$ ―	$ ―	$ -195.70K
Interest Expense	$ ―	$ ―	$ ―	$ ―
EBIT	$ -7.80M	$ -7.31M	$ -915.46K	$ -247.72K
EBITDA	$ -7.80M	$ -7.31M	$ -915.46K	$ -247.72K

Currency in USD

Estrella Immunopharma Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing